[144] METLIFE INC SEC Filing

Rhea-AI Filing Summary

Rule 144 notice: A holder filed to sell 196 shares of common stock through Barclays on the NYSE. The filing lists an aggregate market value of $15,435 and an approximate sale date of 10/29/2025. Shares outstanding were 665,026,054.

The filer reports prior sales in the past three months by related accounts, including 333 shares on 10/01/2025 for gross proceeds of $27,282.69. This notice reflects a proposed secondary sale by an existing holder.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Barclays 745 Seventh Ave New York NY 10019	196	15435	665026054	10/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/15/2013	Purchase	GOLDMAN SACHS			91	05/20/2013	Cash
Common Stock	06/28/2013	Purchase	DEUTSCHE BANK			105	07/03/2013	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	07/31/2025	209	15873.55
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	09/19/2025	64	5066.24
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	09/19/2025	269	21294.04
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	09/19/2025	221	17494.36
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	09/19/2025	17	1345.72
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	10/01/2025	333	27282.69

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is disclosed in MET’s Form 144 filing?

A proposed sale of 196 common shares via Barclays on the NYSE with an aggregate market value of $15,435 and an approximate sale date of 10/29/2025.

How many shares are proposed to be sold under Rule 144?

The notice lists 196 shares of common stock to be sold.

What broker and exchange are named for the sale?

The broker is Barclays, and the exchange named is the NYSE.

What is the aggregate market value of the proposed sale?

The filing states an aggregate market value of $15,435 for the 196 shares.

How many shares are outstanding, as disclosed in the notice?

The filing lists 665,026,054 shares outstanding.

Were there recent sales by related accounts?

Yes. The filing lists multiple sales over the past three months, including 333 shares on 10/01/2025 for $27,282.69 in gross proceeds.